According to DelveInsight's estimates, in the 7MM, the total incident cases of aGvHD for Grade B, Grade C, and Grade D were around 6,000, 3,000, and 2000 , respectively, in 2023, which are expected to ...
It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and ...